Transfusion Medicine Reviews
Volume 24, Issue 2 , Pages 130-139 , April 2010

Optimization of Leukocyte Collection and Monocyte Isolation for Dendritic Cell Culture

  • Erwin F. Strasser

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Erwin F. Strasser, MD, Transfusion Medicine and Hemostasis Department, University Hospital of Erlangen, Krankenhausstr. 12, D-91054 Erlangen, Germany.
    • ,
  • Reinhold Eckstein

References 

  1. Bierman HR, Marshall GJ, Kelly KH, et al. Leukapheresis in man. III. Hematologic observations in patients with leukemia and myeloid metaplasia. Blood. 1963;21:164–182
  2. Freireich EJ, Judson G, Levin RH. Separation and collection of leukocytes. Cancer Res. 1965;25:1516–1520
  3. Frei E, Levin RH, Bodey GP, et al. The nature and control of infections in patients with acute leukemia. Cancer Res. 1965;25:1511–1515
  4. Herzig RH, Herzig GP, Graw RG, et al. Successful PMNC transfusion therapy for gram-negative septicemia. A prospectively randomised controlled study. N Eng J Med. 1977;296:701–705
  5. Alavi JB, Root RK, Djerassi I, et al. A randomized clinical trial of PMNC transfusions for infection in acute leukemia. N Engl J Med. 1977;296:706–711
  6. Mishler JM, Hadlock DC, Fortuny IE, et al. Increased efficiency of leukocyte collection by the addition of hydroxyethyl starch to the continuous flow centrifuge. Blood. 1974;44:571–581
  7. Strauss RG. Current status of PMNC transfusions to treat neonatal sepsis. J Clin Apheresis. 1989;5:25–29
  8. Buckner D, Graw RG, Eisel RJ, et al. Leukapheresis by continuous flow centrifugation (CFC) in patients with chronic myelocytic leukemia (CML). Blood. 1969;33:353–369
  9. Hester JP, Kellogg RM, Mulzet AP, et al. Principles of blood separation and component extraction in a disposable continuous-flow single-stage channel. Blood. 1979;54:254–268
  10. Müller N, Mitschulat H, Wortmann W. Leukocytapheresis: Evaluation of a new procedure for the blood cell separator Fresenius AS 104. Infusionsther Transfusionsmed. 1992;19:70–72
  11. McCredie KB, Hersh EM, Freireich EJ. Cells capable of colony formation in the peripheral blood of man. Science. 1971;171:293–294
  12. Körbling M, Burke P, Braine H, et al. Successful engraftment of blood derived normal hemopoietic stem cells in chronic myelogenous leukemia. Exp Hematol. 1981;9:684–690
  13. Körbling M, Fliedner TM, Pflieger H. Collection of large quantities of PMNC/ macrophage progenitor cells (CFUc) in man by means of continuous-flow leukapheresis. Scand J Haematol. 1980;24:22–28
  14. Cooper IA, Ding JC, Adams PB, et al. Intensive leukapheresis in the management of cytopenias in patients with chronic lymphocytic leukemia (CLL) and lymphocytic lymphoma. Am J Hematol. 1979;6:387–398
  15. Wade PH, Skrabut EM, Vinciquerra L, et al. In vitro function of PMNCs isolated from blood of normal volunteers using continuous-flow centrifugation in the IBM-aminco celltrifuge and adhesion-filtration leukapheresis using nylon fiber. Transfusion. 1977;17:136–140
  16. Zingsem J, Zeiler T, Zimmermann R, et al. Bone marrow processing with the Fresenius AS104: Initial results. J Hematother. 1992;1:273–278
  17. Menichella G, Lai M, Pierelli L, et al. Evaluation of a new protocol for peripheral blood stem cell collection with the Fresenius AS 104 cell separator. J Clin Apher. 1997;12:82–86
  18. Norol F, Scotto F, Duedari N, et al. Peripheral blood stem cell collection with a blood cell separator. Transfusion. 1993;33:894–897
  19. Baker PK, Rhodes EG, Duguid JK. Continuous flow cell separator use for bone marrow processing. Transfus Sci. 1991;12:183–187
  20. Davis JM, Schepers KG, Eby LL, et al. Comparison of progenitor cell concentration techniques: Continuous flow separation versus density-gradient isolation. J Hematother. 1993;2:315–320
  21. Padley D, Strauss RG, Wieland M, et al. Concurrent comparison of the Cobe Spectra and Fenwal CS 3000 for the collection of peripheral blood mononuclear cells for autologous peripheral stem cell transplantation. J Clin Apher. 1991;6:77–80
  22. Glaser A, Schuler-Thurner B, Feuerstein B, et al. Collection of MNCs with two cell separators for adoptive immunotherapy in patients with stage IV melanoma. Transfusion. 2001;41:117–122
  23. Strasser EF, Berger TG, Weisbach V, et al. Comparison of two apheresis systems for the collection of CD14+ cells intended to be used in dendritic cell culture. Transfusion. 2003;43:1309–1316
  24. Morrison AE, Watson D, Buchanan S, et al. Prospective randomised concurrent comparison of the COBE spectra version 4.7, COBE spectra version 6 Auto PBSCtrademark) and Hemonetics MCS+ cell separators for leukapheresis in patients with haematological and non haematological malignancies. J Clin Apher. 2000;15:224–229
  25. Wilke R, Brettell M, Prince HM, et al. Comparison of COBE spectra software version 4.7 PBSC and version 6.0 auto PBSC program. J Clin Apher. 1999;14:26–30
  26. Rowley SD, Prather K, Bui KT, et al. Collection of peripheral blood progenitor cells with an automated leukapheresis system. Transfusion. 1999;39:1200–1206
  27. Rouard H, Leon A, De Reys S, et al. A closed and single-use system for monocyte enrichment: Potential for dendritic cell generation for clinical applications. Transfusion. 2003;43:481–487
  28. Berger TG, Strasser E, Smith R, et al. Efficient elutriation of monocytes within a closed system (Elutra) for clinical-scale generation of dendritic cells. J Immunol Methods. 2005;298:61–72
  29. Erdmann M, Dörrie J, Schaft N, et al. Effective clinical-scale production of dendritic cell vaccines by monocyte elutriation directly in medium, subsequent culture in bags and final antigen loading using peptides or RNA transfection. J Immunother. 2007;30:663–674
  30. Lemarie C, Sugaye R, Kaur I, et al. Purification of monocytes from cryopreserved mobilized apheresis products by elutriation with the Elutra device. J Immunol Methods. 2007;318:30–36
  31. Altuntas F, Kocyigit I, Ozturk A, et al. Comparison of the Fenwal Amicus and Fresenius Com.Tec cell separators for autologous peripheral blood progenitor cell collection. Transfus Apher Sci. 2007;36:159–167
  32. Strasser EF, Hendelmeier M, Weisbach V, et al. CD14+ cell collection in non-cytokine stimulated donors with the COM.TEC cell separator. Transfusion. 2006;46:66–73
  33. Strasser EF, Schremmer M, Hendelmeier M, et al. Automated CD14+ monocyte collection with the autoMNC program of the COM.TEC cell separator. Transfusion. 2007;47:2297–2304
  34. Snyder EL, O'Donnell L, Dengler TJ, et al. Ex vivo evaluation of PBMNCs collected with a new cell separator. Transfusion. 2001;41:940–949
  35. Moog R. Harvesting of CD34 antigen-expressing cells with a new programme for the collection of mononuclear cells with the use of the Amicus (Baxter) blood cell separator. Transfusion Med. 2002;12:367–371
  36. Thomas L, Mansour V, Jain R, et al. Use of the CS-3000 Plus to prepare apheresed blood cells for immunomagnetic positive cell selection. J Hematother. 1995;4:315–321
  37. Moog R, Uppenkamp M, Böck H, et al. Harvesting of peripheral blood progenitor cells with different programmes of discontinuous flow systems. Vox Sang. 1999;76:50–54
  38. Hitzler WE, Wolf S, Runkel S, et al. Comparison of intermittent- and continuous-flow cell separators for the collection of autologous peripheral blood progenitor cells in patients with hematologic malignancies. Transfusion. 2001;41:1562–1566
  39. Heuft HG, Dubiel M, Kingreen D, et al. Automated collection of peripheral blood stem cells with the COBE spectra for autotransplantation. Vox Sang. 2000;79:94–99
  40. Wolf CE, Meyer M, Riggert J. Leukapheresis for the extraction of monocytes and various lymphocyte subpopulations from peripheral blood: Product quality and prediction of the yield using different harvest procedures. Vox Sang. 2005;88:249–255
  41. Jestice HK, Boraks P, Scott MA, et al. Improved yield of peripheral blood progenitor cells on the Cobe Spectra. Bone Marrow Transplant. 1996;18:597–601
  42. Bellavita P, Celega E, Poma R. Comparison of performance of six different cell separators in collecting peripheral blood mononuclear cells. Transfus Sci. 1997;18:215–221
  43. Stroncek DF, Clay ME, Smith J, et al. Comparison of two blood cell separators in collecting peripheral blood stem cell components. Transfus Med. 1997;7:95–99
  44. Heuft HG, Dubiel M, Rick O, et al. Inverse relationship between patient peripheral blood CD34+ cell counts and collection efficiency for CD34+ cells in two automated leukapheresis systems. Transfusion. 2001;41:1008–1013
  45. Ikeda K, Ohto H, Kanno T, et al. Automated programs for collection of mononuclear cells and progenitor cells by two separators for peripheral blood progenitor cell transplantation: Comparison by a randomized crossover study. Transfusion. 2007;47:1234–1240
  46. Shimizu N, Asai T. Analysis for the optimal blood draw speed to collect sufficient peripheral blood mononuclear cells by COBE Spectra. Ther Apher Dial. 2004;8:190–193
  47. Glaser A, Zingsem J, Zimmermann R, et al. Collection of mononuclear cells in the Spectra for the generation of dendritic cells. Transfusion. 1999;39:661–662
  48. Nguyen XD, Eichler H, Sucker A, et al. Collection of autologous monocytes for dendritic cell vaccination therapy in metastatic melanoma patients. Transfusion. 2002;42:428–432
  49. Kissel K, Berber S, Nockher A, et al. Human platelets target dendritic cell differentiation and production of proinflammatory cytokines. Transfusion. 2006;46:818–827
  50. Yanagita M, Kobayashi R, Kashiwagi Y, et al. Thrombin regulated the function of blood dendritic cells. Biochem Biophys Res Commun. 2007;364:318–324
  51. Hamzeh-Cognasse H, Cognasse F, Palle S, et al. Direct contact of platelets and their released products exert different effects on human dendritic cell maturation. BMC Immunol. 2008;9:54–69
  52. Strasser EF, Zimmermann R, Weisbach V, et al. Mononuclear cell variability and recruitment in non-cytokine-stimulated donors after serial 10-liter leukapheresis procedures. Transfusion. 2005;45:445–452
  53. Faradji A, Bohbot A, Schmitt-Goguel M, et al. Apheresis-elutriation program for adoptive immunotherapy with autologous activated monocytes in cancer patients. Int J Artif Organs. 1991;14:304–312
  54. Faradji A, Bohbot A, Schmitt-Goguel M, et al. Large scale isolation of human blood monocytes by continuous flow centrifugation leukapheresis and counterflow centrifugation elutriation for adoptive cellular immunotherapy in cancer patients. J Immunol Methods. 1994;174:297–309
  55. Schwanke U, Nabereit A, Moog R. Isolation of monocytes from whole blood-derived buffy coats by continuous counter-flow elutriation. J Clin Apher. 2006;21:153–157
  56. Elias M, von Zanten J, Hospers GA, et al. Closed system generation of dendritic cells from a single blood volume for clinical application in immunotherapy. J Clin Apher. 2005;20:197–207
  57. Suen Y, Lee SM, Aono F, et al. Comparison of monocyte enrichment by immuno-magnetic depletion or adherence for the clinical-scale generation of DC. Cytotherapy. 2001;3:365–375
  58. Pullarkat V, Lau R, Lee SM, et al. Large-scale monocyte enrichment coupled with a closed culture system for the generation of human dendritic cells. J Immunol Methods. 2002;267:173–183
  59. Meyer-Wentrup F, Burdach S. Efficacy of dendritic cell generation for clinical use: Recovery and purity of monocytes and mature dendritic cells after immunomagnetic sorting or adherence selection of CD14+ starting population. J Hematother Stem Cell Res. 2003;12:289–299
  60. Sorg RV, Ozcan Z, Brefort T, et al. Clinical-scale generation of dendritic cells in a closed system. J Immunother. 2003;26:374–383
  61. Craig DH, Shiratsuchi H, Basson MD. Increased extracellular pressure provides a novel adjuvant stimulus for enhancement of conventional dendritic cell maturation strategies. Biochem Biophys Res Commun. 2009;387:174–179
  62. Shortman K, Neik SH. Steady-state and inflammatory dendritic-cell development. Nature Rev Immunol. 2007;7:19–30
  63. Tacke F, Randolph GJ. Migratory fate and differentiation of blood monocyte subsets. Immunobiology. 2006;211:609–618
  64. Bonasio R, Scimone ML, Schaerli P, et al. Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus. Nature Immunol. 2006;7:1092–1100
  65. Hume DA. The mononuclear phagocyte system. Cur Opin Immunol. 2006;18:49–53
  66. Geissmann F, Jung S, Littmann DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity. 2003;19:71–82
  67. Alejandro López J, Crosbie G, Kelly C, et al. Monitoring and isolation of blood dendritic cells from apheresis products in healthy individuals: A platform for cancer immunotherapy. J Immunol Methods. 2002;267:199–212
  68. Strasser EF, Keller B, Hendelmeier M, et al. Short-term liquid storage of CD14+ monocytes, CD11c+, and CD123+ precursor dendritic cells produced by leukocytapheresis. Transfusion. 2007;47:1241–1249
  69. Colonna M, Trinchieri G, Liu YJ. Plasmacytoid dendritic cells in immunity. Nature Immunol. 2004;5:1219–1226
  70. Liu YJIPC. Professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol. 2005;23:275–306
  71. McKenna K, Beignon AS, Bhardwaj N. Plasmacytoid dendritic cells: Linking innate and adaptive immunity. J Virol. 2005;79:17–27
  72. Grouard G, Durand I, Filgueira L, et al. Dendritic cells capable of stimulation T cells in germinal centres. Nature. 1996;384:364–367
  73. Romani N, Gruner S, Brang D, et al. Proliferating dendritic cell progenitors in human blood. J Exp Med. 1994;180:83–93
  74. Caux C, Vanbervliet B, Massacrier C, et al. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF + TNF alpha. J Exp Med. 1996;184:695–706
  75. Strobl H, Riedl E, Scheinecker C, et al. TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors. J Immunol. 1996;157:1499–1507
  76. Balan S, Kale VP, Limaye LS. A simple two-step culture system for the large scale generation of mature and functional dendritic cells from umbilical cord blood CD34+ cells. Transfusion. 2009;49:2109–2121
  77. Schuler G, Steinman RM. Dendritic cells as adjuvants for immune-mediated resistance to tumors. J Exp Med. 1997;186:1183–1187
  78. Thurner B, Röder C, Dieckmann D, et al. Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. J Immunol Methods. 1999;223:1–15
  79. Schuler G, Schuler-Thurner B, Steinman RM. The use of dendritic cells in cancer immunotherapy. Curr Opin Immunol. 2003;15:138–147
  80. Tuyaerts S, Aerts JL, Corthals J, et al. Current approaches in dendritic cell generation and future implications for cancer immunotherapy. Cancer Immunol Immunother. 2007;56:1513–1537
  81. Steinman RM. Dendritic cells in vivo: A key target for a new vaccine science. Immunity. 2008;29:319–324
  82. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature. 2007;449:419–426

PII: S0887-7963(09)00122-9

doi: 10.1016/j.tmrv.2009.11.004

Transfusion Medicine Reviews
Volume 24, Issue 2 , Pages 130-139 , April 2010

Article Tools